CAMP inhibits migration, ruffling and paxillin accumulation in focal adhesions of pancreatic ductal adenocarcinoma cells: Effects of PKA and EPAC

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 12, 2013, Pages 2664-2672

  Burdyga, Alex ^a   Conant, Alan ^a   Haynes, Lee ^a   Zhang, Jin ^b   Jalink, Kees ^c   Sutton, Robert ^a   Neoptolemos, John ^d   Costello, Eithne ^a,d   Tepikin, Alexei ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

^d Duncan Building ^*  (United Kingdom)

Author keywords

CAMP; Cell migration; EPAC; Pancreatic ductal adenocarcinoma; Paxillin; PKA

Indexed keywords

ANTIPORTER; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; ISOBUTYLMETHYLXANTHINE; PAXILLIN;

ARTICLE; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; FOCAL ADHESION; HUMAN; HUMAN CELL; PANCREAS ADENOCARCINOMA; PERMEABILITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 84882579435     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.06.011     Document Type: Article

References (45)

1. Almahariq M., Tsalkova T., Mei F.C., Chen H., Zhou J., Sastry S.K., Schwede F., Cheng X. A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion. Mol. Pharmacol. 2013, 83:122-128.
2. Aumo L., Rusten M., Mellgren G., Bakke M., Lewis A.E. Functional roles of protein kinase A (PKA) and exchange protein directly activated by 3',5'-cyclic adenosine 5'-monophosphate (cAMP) 2 (EPAC2) in cAMP-mediated actions in adrenocortical cells. Endocrinology 2010, 151:2151-2161.
3. Baljinnyam E., De Lorenzo M.S., Xie L.H., Iwatsubo M., Chen S., Goydos J.S., Nowycky M.C., Iwatsubo K. Exchange protein directly activated by cyclic AMP increases melanoma cell migration by a Ca2+-dependent mechanism. Cancer Res. 2010, 70:5607-5617.
4. Campbell P.J., Yachida S., Mudie L.J., Stephens P.J., Pleasance E.D., Stebbings L.A., Morsberger L.A., Latimer C., McLaren S., Lin M.L., McBride D.J., Varela I., Nik-Zainal S.A., Leroy C., Jia M., Menzies A., Butler A.P., Teague J.W., Griffin C.A., Burton J., Swerdlow H., Quail M.A., Stratton M.R., Iacobuzio-Donahue C., Futreal P.A. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010, 467:1109-1113.
5. Carpenter A.E., Jones T.R., Lamprecht M.R., Clarke C., Kang I.H., Friman O., Guertin D.A., Chang J.H., Lindquist R.A., Moffat J., Golland P., Sabatini D.M. Cell profiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006, 7:R100.
6. Chen L., Zhang J.J., Huang X.Y. cAMP inhibits cell migration by interfering with Rac-induced lamellipodium formation. J. Biol. Chem. 2008, 283:13799-13805.
7. Cheng X., Ji Z., Tsalkova T., Mei F. Epac and PKA: a tale of two intracellular cAMP receptors. Acta Biochim. Biophys. Sin. (Shanghai) 2008, 40:651-662.
8. Costello E., Greenhalf W., Neoptolemos J.P. New biomarkers and targets in pancreatic cancer and their application to treatment. Nat. Rev. Gastroenterol. Hepatol. 2012, 9:435-444.
9. Costello E., Neoptolemos J.P. Pancreatic cancer in 2010: new insights for early intervention and detection. Nat. Rev. Gastroenterol. Hepatol. 2011, 8:71-73.
10. Deer E.L., Gonzalez-Hernandez J., Coursen J.D., Shea J.E., Ngatia J., Scaife C.L., Firpo M.A., Mulvihill S.J. Phenotype and genotype of pancreatic cancer cell lines. Pancreas 2010, 39:425-435.
11. Deming P.B., Campbell S.L., Baldor L.C., Howe A.K. Protein kinase A regulates 3-phosphatidylinositide dynamics during platelet-derived growth factor-induced membrane ruffling and chemotaxis. J. Biol. Chem. 2008, 283:35199-35211.
12. Depry C., Allen M.D., Zhang J. Visualization of PKA activity in plasma membrane microdomains. Mol. Biosyst. 2011, 7:52-58.
13. Depry C., Zhang J. Visualization of kinase activity with FRET-based activity biosensors. Curr. Protoc. Mol. Biol. 2010, Chapter 18. (Unit 18).
14. Enserink J.M., Christensen A.E., de Rooij J., van Triest M., Schwede F., Genieser H.G., Doskeland S.O., Blank J.L., Bos J.L. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol. 2002, 4:901-906.
15. Farrow B., Rychahou P., Murillo C., O'Connor K.L., Iwamura T., Evers B.M. Inhibition of pancreatic cancer cell growth and induction of apoptosis with novel therapies directed against protein kinase A. Surgery 2003, 134:197-205.
16. Grandoch M., Rose A., ter Braak M., Jendrossek V., Rubben H., Fischer J.W., Schmidt M., Weber A.A. Epac inhibits migration and proliferation of human prostate carcinoma cells. Br. J. Cancer 2009, 101:2038-2042.
17. Grashoff C., Hoffman B.D., Brenner M.D., Zhou R., Parsons M., Yang M.T., McLean M.A., Sligar S.G., Chen C.S., Ha T., Schwartz M.A. Measuring mechanical tension across vinculin reveals regulation of focal adhesion dynamics. Nature 2010, 466:263-266.
18. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
19. Howe A.K. Regulation of actin-based cell migration by cAMP/PKA. Biochim. Biophys. Acta 2004, 1692:159-174.
20. Howe A.K. Cross-talk between calcium and protein kinase A in the regulation of cell migration. Curr. Opin. Cell Biol. 2011, 23:554-561.
21. Howe A.K., Baldor L.C., Hogan B.P. Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:14320-14325.
22. Huttenlocher A., Horwitz A.R. Integrins in cell migration. Cold Spring Harb. Perspect. Biol. 2011, 3:a005074.
23. Iwamura T., Katsuki T., Ide K. Establishment and characterization of a human pancreatic cancer cell line (SUIT-2) producing carcinoembryonic antigen and carbohydrate antigen 19-9. Jpn. J. Cancer Res. 1987, 78:54-62.
24. Laukaitis C.M., Webb D.J., Donais K., Horwitz A.F. Differential dynamics of alpha 5 integrin, paxillin, and alpha-actinin during formation and disassembly of adhesions in migrating cells. J. Cell Biol. 2001, 153:1427-1440.
25. Lim C.J., Kain K.H., Tkachenko E., Goldfinger L.E., Gutierrez E., Allen M.D., Groisman A., Zhang J., Ginsberg M.H. Integrin-mediated protein kinase A activation at the leading edge of migrating cells. Mol. Biol. Cell 2008, 19:4930-4941.
26. Lissandron V., Terrin A., Collini M., D'alfonso L., Chirico G., Pantano S., Zaccolo M. Improvement of a FRET-based indicator for cAMP by linker design and stabilization of donor-acceptor interaction. J. Mol. Biol. 2005, 354:546-555.
27. Lorenz R., Aleksic T., Wagner M., Adler G., Weber C.K. The cAMP/Epac1/Rap1 pathway in pancreatic carcinoma. Pancreas 2008, 37:102-103.
28. Lyle K.S., Raaijmakers J.H., Bruinsma W., Bos J.L., de Rooij J. cAMP-induced Epac-Rap activation inhibits epithelial cell migration by modulating focal adhesion and leading edge dynamics. Cell. Signal. 2008, 20:1104-1116.
29. McKenzie A.J., Campbell S.L., Howe A.K. Protein kinase A activity and anchoring are required for ovarian cancer cell migration and invasion. PLoS One 2011, 6:e26552.
30. O'Connor K.L., Mercurio A.M. Protein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells. J. Biol. Chem. 2001, 276:47895-47900.
31. O'Connor K.L., Nguyen B.K., Mercurio A.M. RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism. J. Cell Biol. 2000, 148:253-258.
32. Paulucci-Holthauzen A.A., Vergara L.A., Bellot L.J., Canton D., Scott J.D., O'Connor K.L. Spatial distribution of protein kinase A activity during cell migration is mediated by A-kinase anchoring protein AKAP Lbc. J. Biol. Chem. 2009, 284:5956-5967.
33. Ponsioen B., Zhao J., Riedl J., Zwartkruis F., van der Krogt G., Zaccolo M., Moolenaar W.H., Bos J.L., Jalink K. Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep. 2004, 5:1176-1180.
34. Rhim A.D., Mirek E.T., Aiello N.M., Maitra A., Bailey J.M., McAllister F., Reichert M., Beatty G.L., Rustgi A.K., Vonderheide R.H., Leach S.D., Stanger B.Z. EMT and dissemination precede pancreatic tumor formation. Cell 2012, 148:349-361.
35. Ridley A.J. Life at the leading edge. Cell 2011, 145:1012-1022.
36. Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25years of image analysis. Nat. Methods 2012, 9:671-675.
37. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2013. CA Cancer J. Clin. 2013, 63:11-30.
38. Subach O.M., Entenberg D., Condeelis J.S., Verkhusha V.V. A FRET-facilitated photoswitching using an orange fluorescent protein with the fast photoconversion kinetics. J. Am. Chem. Soc. 2012, 134:14789-14799.
39. Tkachenko E., Sabouri-Ghomi M., Pertz O., Kim C., Gutierrez E., Machacek M., Groisman A., Danuser G., Ginsberg M.H. Protein kinase A governs a RhoA-RhoGDI protrusion-retraction pacemaker in migrating cells. Nat. Cell Biol. 2011, 13:660-667.
40. Tuveson D.A., Neoptolemos J.P. Understanding metastasis in pancreatic cancer: a call for new clinical approaches. Cell 2012, 148:21-23.
41. van der Krogt G.N., Ogink J., Ponsioen B., Jalink K. A comparison of donor-acceptor pairs for genetically encoded FRET sensors: application to the Epac cAMP sensor as an example. PLoS One 2008, 3:e1916.
42. Yachida S., Jones S., Bozic I., Antal T., Leary R., Fu B., Kamiyama M., Hruban R.H., Eshleman J.R., Nowak M.A., Velculescu V.E., Kinzler K.W., Vogelstein B., Iacobuzio-Donahue C.A. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010, 467:1114-1117.
43. Zaccolo M., De G.F., Cho C.Y., Feng L., Knapp T., Negulescu P.A., Taylor S.S., Tsien R.Y., Pozzan T. A genetically encoded, fluorescent indicator for cyclic AMP in living cells. Nat. Cell Biol. 2000, 2:25-29.
44. Zaccolo M., Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 2002, 295:1711-1715.
45. Zhang J., Ma Y., Taylor S.S., Tsien R.Y. Genetically encoded reporters of protein kinase A activity reveal impact of substrate tethering. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:14997-15002.